Skip to main content
John R. Zalcberg on Muck Rack

John R. Zalcberg

As seen in: Color Research & Application, Nature, Wiley Online Library, Therapeutic Advances in Medical Oncology, BMJ Quality & Safety, Frontiers, MDPI, SAGE Publishing, The Conversation, JAMA (The Journal of the American Medical Association) and
Cancer physician, GI medical oncologist, Professor of Cancer Research at School of Public health at Monash Uni, slow cyclist, professional student of the sax
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with John R.

Contact John R., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Feasibility and outcomes of the DNA Screen nationwide adult genomic screening pilot - Nature Health

|
By Paul Lacaze, Jane Tiller, Tu Nguyen-Dumont, Amanda Willis, Lucas A. Mitchell, Bronwyn Terrill, Ari Horton, Robert Green, Ranjit Manchanda, Roger Milne, Jing Pang, Gerald Watts, Nicola K Poplawski, Kathy Tucker, Mathew Wallis, Nicholas Pachter, Paul James, John R. Zalcberg, John McNeil, John Mcneil
| Nature Verified
Abstract Population genomic screening enables the identification of individuals at high risk of medically actionable conditions before disease onset, yet real-world feasibility studies are lacking. Informed by prior cost-effectiveness modelling, we conducted a prospective nationwide pilot targeting young adults in Australia (aged 18–40 years), offering genomic screening for ten genes linked to hereditary breast and ovarian cancer, Lynch syndrome and familial hypercholesterolaemia.
Open in Who Shared Issue with article?

Do routine narrative style CT reports provide sufficient information to adequately stage pancreatic cancer

|
By Samantha Ellis, John R. Zalcberg, Charles Pilgrim, Hepatopancreaticobiliary Surgery
| HPB Verified
Get full text access Log in, subscribe or purchase for full access. References 1. Welfare AIoHa. Cancer data in Australia. Canberra, Australia: Australian Institute of Health and Welfare; 2023. 2. J, D. Structured reporting in cancer imaging: reaching the quality dimension in communication HealthManagement. 2016; 15 3. Isaji, S. ∙ Mizuno, S. ∙ Windsor, J.A. ... International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017 Pancreatology. 2018; 18:2-11 4.
Open in Who Shared Issue with article?

Assessing the impact of an intensive dietitian-led telehealth intervention focusing on nutritional adequacy, symptom control and optional supplemental jejunal feeding, on quality of life in patients with pancreatic cancer: a randomised controlled trial pr

|
By de Boo, Kate Furness, J Simon, Charles H.C, Lauren Hanna, Kate Connell, Terrence P Haines, Catherine E. Huggins, John R. Zalcberg, Sharon Carey, Charles Pilgrim, Joanne Lundy, Andrew Metz Verified, David W. Kissane, Michael Franco, John Coutsouvelis, Emma McShane, J Simon Bel
| Nutrition Journal Verified
This study is a two-arm, multicentred, randomised controlled trial. Outcomes will be measured at baseline, three, and six-month follow-up time points. Figure 2 represents the study design and participant flow. The study flow chart depicts the two pathways; the intervention and usual care group. The usual care group will be screened for malnutrition at their healthcare services and will be referred to a dietitian when clinically indicated.
Open in Who Shared Issue with article?
See all 36 licensed articles (38 Total)